DSIP: What It Is and What It Does

What DSIP is

DSIP (delta sleep-inducing peptide) is a nonapeptide, nine amino acids long, isolated in 1977 from the cerebral venous blood of rabbits during induced sleep. It is supplied as an analytical-grade reference material for laboratory research.

Where it comes from

Schoenenberger and Monnier isolated DSIP in 1977 by cross-circulating blood between rabbits: when one animal was put into delta sleep by stimulating its thalamus, a factor in its cerebral venous blood produced delta activity in a recipient. The nine-residue sequence (Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) was determined and synthesised, and for a decade the peptide was studied intensely. No receptor was ever pinned down, and by 2006 a Journal of Neurochemistry review could still call it an unresolved riddle.

What it does — in plain terms

The name promises more than the literature delivers. Early work reported that DSIP nudged animals toward slow-wave (delta) sleep, and a small 1987 trial reported better sleep measures in chronic insomniacs. Later reviews found the sleep effect inconsistent and turned to other observations: stress responses, pain thresholds, circadian rhythms, and recovery in stroke models.

How it works

Nobody has identified a DSIP receptor, and the peptide is broken down quickly in blood, so how it acts is inferred rather than known. Proposed routes include effects on GABA and glutamate signalling, on opioid and monoamine systems, and on the hypothalamic-pituitary axis.

Some of the more reproducible observations concern stress rather than sleep: in animal work DSIP and related preparations blunted stress-induced changes in behaviour and hormones. A 2009 review in Obesity Reviews even proposed a link to circadian mechanisms via the glucocorticoid-induced leucine zipper.

A practical complication for researchers is that the native peptide is unstable; phosphorylated and other modified forms were made to survive longer, and some of the animal results were obtained with those analogues rather than DSIP itself.

What the research shows

DSIP has one of the longest and least settled research histories of any peptide in this catalog. There is real published work, including a controlled clinical trial, but the sleep-inducing effect that gave it its name has not held up consistently, most of the evidence is old and small, and modern studies are animal models. Anyone working with it should read the 2006 critical review before the earlier enthusiasm.

• Neuroscience and Biobehavioral Reviews, 1984 — summarised the first years of DSIP research: the isolation from sleeping rabbits, the synthetic peptide, and the mixed picture already emerging on its sleep effects.
• Journal of Neurochemistry, 2006 — reviewed three decades of work and concluded the peptide remained an unresolved riddle: no receptor, inconsistent sleep data, and a range of other reported effects that did not fit one mechanism.
• International Journal of Clinical Pharmacology Research, 1987 — a small controlled trial reported improved sleep measures in chronic insomniacs after short-term administration; the trial is old and small and has not been replicated at scale.
• Neuroscience and Behavioral Physiology, 2008 — compared DSIP with the related preparation Deltaran in animal models of stress, reporting protective effects on stress-related behaviour and physiology.
• Molecules, 2021 — reported that DSIP improved recovery of motor function in rats after an experimentally induced focal stroke.

What DSIP is studied for

Slow-wave sleep. The original observation and the source of the name. Results across species and studies were inconsistent, which is the central problem later reviews wrestle with.

Stress responses. A more reproducible line of animal work in which DSIP or its analogues reduced stress-induced behavioural and hormonal changes.

Circadian and endocrine rhythms. DSIP levels vary with time of day, and several studies examined its interaction with cortisol, growth hormone and other rhythmic hormones.

Brain-injury models. Recent rodent studies looked at recovery after stroke and at sleep and memory under high-altitude hypoxia, using the native or a phosphorylated peptide.

Storage & handling

As a lyophilized (freeze-dried) powder, DSIP reference material is most stable kept cold and dark, refrigerated or frozen for longer holds. The native peptide is short-lived in solution: reconstitute with bacteriostatic water, refrigerate at roughly 2-8 °C, keep out of light, and avoid repeated freeze-thaw cycles.